CD79A and autoimmune polyendocrinopathy: Currently, many of the studies that evaluate the contribution of IgA aB2GP1 to obstetrical APS manifestations included small cohorts without a representative number of isolated IgA aB2GP1 positive patients and obtained a poor correlation [33,41,45].